Your browser is no longer supported. Please, upgrade your browser.
Settings
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E41.92 EPS (ttm)1.13 Insider Own0.20% Shs Outstand1.51B Perf Week-0.23%
Market Cap71.33B Forward P/E19.68 EPS next Y2.41 Insider Trans-16.07% Shs Float1.50B Perf Month9.12%
Income1.72B PEG4.35 EPS next Q0.42 Inst Own70.10% Short Float0.76% Perf Quarter7.83%
Sales20.25B P/S3.52 EPS this Y-10.30% Inst Trans1.22% Short Ratio2.07 Perf Half Y12.38%
Book/sh15.04 P/B3.15 EPS next Y12.06% ROA8.30% Target Price48.09 Perf Year21.68%
Cash/sh3.24 P/C14.63 EPS next 5Y9.63% ROE14.70% 52W Range36.08 - 47.88 Perf YTD5.78%
Dividend0.96 P/FCF- EPS past 5Y-21.10% ROI5.70% 52W High-1.32% Beta0.62
Dividend %2.03% Quick Ratio1.30 Sales past 5Y-8.00% Gross Margin54.50% 52W Low30.97% ATR0.72
Employees69000 Current Ratio1.50 Sales Q/Q5.60% Oper. Margin15.00% RSI (14)61.27 Volatility1.09% 1.63%
OptionableYes Debt/Eq0.34 EPS Q/Q35.50% Profit Margin17.30% Rel Volume1.01 Prev Close47.37
ShortableYes LT Debt/Eq0.16 EarningsJan 29 BMO Payout38.40% Avg Volume5.52M Price47.25
Recom2.20 SMA202.51% SMA504.40% SMA20010.98% Volume3,680,480 Change-0.25%
Jan-30-15Reiterated Stifel Buy $47 → $49
Jan-30-15Reiterated Barclays Equal Weight $43 → $48
Sep-22-14Reiterated RBC Capital Mkts Outperform $44 → $48
Jul-17-14Reiterated Stifel Buy $42 → $47
Jul-17-14Reiterated Barclays Equal Weight $40 → $43
Mar-10-14Initiated Singular Research Sell $30
Dec-16-13Reiterated Deutsche Bank Hold $37 → $39
Oct-07-13Reiterated Stifel Buy $44 → $40
Jul-18-13Reiterated Barclays Equal Weight $35 → $37
May-28-13Reiterated RBC Capital Mkts Outperform $38 → $42
May-21-13Initiated Gabelli & Co Buy
Apr-19-13Reiterated RBC Capital Mkts Outperform $37 → $38
Apr-18-13Reiterated Stifel Buy $40 → $44
Apr-12-13Reiterated Deutsche Bank Hold $33 → $35
Feb-15-13Initiated Stifel Nicolaus Buy $40
Jan-11-13Reiterated UBS Buy $75 → $38
Jan-11-13Initiated Barclays Equal Weight $35
Jan-04-13Downgrade Deutsche Bank Buy → Hold $70 → $33
Jul-19-12Reiterated UBS Buy $68 → $72
Mar-19-12Reiterated UBS Buy $62 → $68
Feb-27-15 05:05PM  Mylan inversion deal completed at bizjournals.com
04:15PM  Interested In Pharmaceutical Stocks? Try Novartis (ADR) at Investopedia
01:30PM  Will Mylan (MYL) Beat Earnings on New Product Launches? - Analyst Blog Zacks
01:22PM  ABBOTT LABORATORIES Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and EDGAR Online
01:03PM  ABBOTT LABORATORIES Files SEC form 10-K, Annual Report EDGAR Online
12:30PM  Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business PR Newswire
07:00AM  Compelling Financial Benefit in Valeant's Latest Buy Morningstar
Feb-25-15 08:16AM  Allergan: A new position for Glenview Capital Management Market Realist
Feb-23-15 01:57PM  3 Companies That Could Be Negatively Impacted By Johnson & Johnson Sale Of Cordis Benzinga
Feb-20-15 05:39PM  Three Top Stocks Break Out As Market Stages Reversal at Investor's Business Daily
10:36AM  Abbott Declares 365th Consecutive Quarterly Dividend PR Newswire
Feb-19-15 10:45PM  Billionaire Bill Ackmans Top Picks: Allergan Inc. (AGN), Air Products & Chemicals Inc. (APD), Canadian Pacific Railway Limited (USA) (CP) at Insider Monkey
07:25PM  How to Build a Better Network at the Office at The Wall Street Journal
09:00AM  Abbott to Present at Cowen and Company 35th Annual Health Care Conference PR Newswire
Feb-18-15 08:43AM  Time to Take Another Look at Oculus Innovative Sciences Company Spotlight
Feb-11-15 03:28PM  Zoetis Profit Up 20%, 2015 Outlook Cut Slightly at The Wall Street Journal
10:56AM  Zoetis Beats on Q4 Earnings, Provides In-Line 2015 Outlook - Analyst Blog Zacks
Feb-10-15 03:02PM  Mylan Faces Patent Infringement Lawsuit for Nexavar - Analyst Blog Zacks
11:19AM  Why Pfizer is Worth $40 at Barrons.com
Feb-09-15 02:31PM  Pfizer's Hospira Acquisition Good for Its Stock But What About Its Bonds? at Barrons.com
Feb-07-15 12:01AM  AbbVie: Big Pharma at a Discount Price at Barrons.com
Feb-04-15 09:00AM  Abbott to Present at Leerink Global Healthcare Conference PR Newswire
Feb-03-15 04:35PM  Mylan to Buy Famy Care Businesses, Boost Women's Health - Analyst Blog Zacks
04:01PM  Insulet Extends Exclusive Agreement for Blood Glucose Monitoring Marketwired
Feb-02-15 12:48PM  Mylan Makes Deals In Women's Health, Lung Disease at Investor's Business Daily
Feb-01-15 08:09AM  How a baby formula maker scored a viral hit at Fortune
Jan-30-15 10:10AM  Company News for January 30, 2015 - Corporate Summary Zacks
09:31AM  Abbott Laboratories (ABT) Stock Upgraded Today at Bank of America/Merrill Lynch at TheStreet
09:30AM  Zacks Rank #5 Additions for Friday - Tale of the Tape Zacks
09:02AM  Abbott Launches New Options for People with Cataracts in the United States Benzinga
09:00AM  Abbott Launches New Options for People with Cataracts in the United States PR Newswire
08:51AM  Analysts' Actions: Abbott, Groupon, Procter & Gamble, Visa, More TheStreet
Jan-29-15 04:54PM  Thursday's Market Recap Yahoo Finance Contributors
04:11PM  At Least One CEO Isn't Going to Use Currencies as an Excuse Bloomberg
03:15PM  Abbott CEO losing no sleep over stronger dollar Reuters
02:39PM  Thermo Fisher, Varian, Abbott Up On Earnings Reports at Investor's Business Daily
02:37PM  Abbott Laboratories (ABT) Earnings Report: Q4 2014 Conference Call Transcript at TheStreet
01:04PM  Mylan says shareholders approve Abbott business purchase AP
11:23AM  Abbott Labs' (ABT) Q4 Earnings Up, Guides Below Estimates - Analyst Blog Zacks
11:18AM  Mylan Shareholders Overwhelmingly Approve Agreement Implementing Acquisition of Abbott's Non-U.S. Developed Markets Specialty and Branded Generics Business PR Newswire
09:33AM  Abbott Labs 2015 outlook largely in line with estimates Reuters
09:32AM  Abbott Labs (ABT) Earnings up Y/Y, Stent Sales Decline - Tale of the Tape Zacks
09:00AM  Abbott Laboratories Earnings Call scheduled for 9:00 am ET today CCBN
08:47AM  ABBOTT LABORATORIES Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
08:42AM  Abbott Laboratories Profit Grows 54% at The Wall Street Journal
08:12AM  Abbott beats 4Q profit forecasts AP
08:04AM  Abbott Labs posts sales decline in nutrition business at MarketWatch
07:59AM  Abbott Labs profit beats Street estimates Reuters
07:45AM  Abbott Reports Fourth-Quarter 2014 Results PR Newswire
07:07AM  Q4 2014 Abbott Laboratories Earnings Release - Before Market Open CCBN
Jan-28-15 06:30PM  Will Abbott Labs (ABT) Disappoint on Earnings This Quarter? - Analyst Blog Zacks
01:55PM  Abbot Laboratories (ABT) Stock Gains Today on $5.3 Billion Generic Business Sale Approval at TheStreet
01:21PM  EU mergers and takeovers (Jan 28) Reuters
11:30AM  EU approves Mylan purchase of Abbot generics, subject to conditions Reuters
09:30AM  The Zacks Analyst Blog Highlights: Goldman Sachs, Philip Morris International, Coca-Cola and Abbott Laboratories - Press Releases Zacks
09:28AM  Zacks Rank #5 Additions for Wednesday - Tale of the Tape Zacks
06:05AM  Up to Speed: Peltz receives ammo in fight against DuPont (Video) at American City Business Journals
Jan-27-15 05:01PM  ABBOTT LABORATORIES Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
03:19PM  3 Stocks to Sell as Greece Concerns Intensify Euro Slide - Analyst Blog Zacks
Jan-21-15 10:50PM  J&J Seeks Billions in Trial Over Decade-Old Bidding War at Bloomberg
07:36PM  J&J's $7.2 bln claim against Boston Scientific now with U.S. judge Reuters
Jan-19-15 10:47PM  Tapping China's 'Silver Hair Industry' at The Wall Street Journal
Jan-15-15 09:00AM  Abbott Announces Results of Tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022 PR Newswire
Jan-14-15 05:45PM  DexCom Declares Preliminary Q4 '14 Revenues, Guides '15 - Analyst Blog Zacks
04:30PM  Moody's Upgrades Eight and Affirms 11 Classes of BACM 2007-3 at Moody's
07:00AM  Abbott Laboratories (ABT): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Jan-13-15 02:30PM  Street Talk: HLT, ABT, BBY & AMZN CNBC
09:26AM  Abbott Laboratories (ABT) Stock Lower Today After Jefferies Downgrade at TheStreet
Jan-12-15 10:44AM  Twelve Year Breakout Reaps Rewards at Forbes
Jan-08-15 09:00AM  Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2014 Earnings PR Newswire
Jan-05-15 10:43AM  It's all about oil, the euro and a strong dollar at CNBC
Jan-04-15 06:54PM  U.S. Healthcare Spending On Track To Hit $10,000 Per Person This Year at Forbes
Dec-31-14 01:31PM  Seek value, not momentum: Pro CNBC
Dec-30-14 09:00AM  Abbott Announces Early Results of Tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022 PR Newswire
Dec-23-14 05:04PM  ABBOTT LABORATORIES Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
03:33PM  Rising Services Spending Could Prop Up Healthcare, Tech ETFs ETF Trends
02:29PM  Chilean quits company boards to fight U.S. insider trading charges Reuters
12:32PM  How to play the third-quarter GDP beat at CNBC
Dec-22-14 04:30PM  Abbott Completes Acquisition of Topera, Inc. PR Newswire
02:32PM  U.S. regulator charges two with insider trading in Abbott deal Reuters
Dec-18-14 09:00AM  Abbott to Present at J.P. Morgan Healthcare Conference PR Newswire
Dec-17-14 06:52PM  Philips Buying Volcano To Boost Image-Guided Therapy at Investor's Business Daily
Dec-15-14 09:00AM  Abbott Commences Tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022 PR Newswire
Dec-12-14 01:02PM  Midday Movers: Exxon Mobil, Morgan Stanley & more at CNBC
12:59PM  Abbott Labs raises dividend to 24 cents AP
11:28AM  Abbott raises quarterly dividend to 24 cents a share from 22 cents at MarketWatch
11:18AM  Abbott Announces Increase in Quarterly Dividend PR Newswire
10:28AM  U.S. stocks renew fall as oil demand seen slowing at MarketWatch
12:00AM  Abbott Completes Acquisition of Veropharm PR Newswire
Dec-11-14 03:00AM  Abbott's Pioneering, Infectious Disease Testing Platform, IRIDICA, Now Available in Europe PR Newswire
Dec-10-14 12:01PM  Zoetis: An attractive business model Market Realist
08:55AM  Pharmalot, Pharmalittle: We're Reading About Mylan, AbbVie and Lots More!! at The Wall Street Journal
Dec-09-14 12:28PM  The Dollar and the Damage Done at Barrons.com
Dec-06-14 05:06AM  France, Germany suspend some drug approvals over Indian data Reuters
Dec-04-14 11:00AM  Impact of Malnutrition in U.S. at $157 Billion Annually PR Newswire
Dec-03-14 01:21PM  Bulls can't get enough of Abbott Labs optionMONSTER
11:54AM  Abbott Goes Beyond House of Brands, Boosts Parent Company Marketing at The Wall Street Journal
07:14AM  Abbott Labs attracts bullish trades optionMONSTER
Dec-02-14 06:36PM  Your first trade for Wednesday at CNBC
05:58PM  Your first trade tomorrow: CP, ABT, BBRY & F CNBC
Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome, intrahepatic cholestasis or depressive symptoms, gynecological disorders, dyslipidemia, hypertension, hypothyroidism, pain, fever, and inflammation; and regulates physiological rhythm of the colon, as well as provides hormone replacement therapy and anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; hematology systems and reagents; genomic-based tests; informatics and automation solutions; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products, such as various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular diseases. Abbott Laboratories also offers blood glucose and glucose monitoring systems, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, such as cataract surgery, LASIK surgery, and contact lens care and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. It has strategic alliance with Fonterra Co-operative Group Ltd. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Contreras JaimeSenior Vice PresidentFeb 18Sale46.2642319,5681,379Feb 18 05:49 PM
Simhambhatla Murthy VSenior Vice PresidentFeb 17Sale46.411727,98345,199Feb 19 05:11 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 17Sale46.381727,97851,941Feb 19 05:12 PM
Pavee Jean-YvesSenior Vice PresidentFeb 17Sale46.4162128,82122,912Feb 18 06:45 PM
Funck Robert EVice President, ControllerFeb 13Option Exercise22.2710,542234,73973,468Feb 17 05:55 PM
CAPEK JOHN MExecutive Vice PresidentFeb 04Option Exercise25.2583,0002,095,426309,945Feb 06 05:11 PM
CAPEK JOHN MExecutive Vice PresidentFeb 04Sale45.7638,7731,774,430236,880Feb 06 05:11 PM
CAPEK JOHN MExecutive Vice PresidentFeb 04Sale45.839,935455,340226,945Feb 06 05:12 PM
CAPEK JOHN MExecutive Vice PresidentFeb 04Sale45.6634,2921,565,612275,653Feb 06 05:11 PM
Contreras JaimeSenior Vice PresidentNov 25Option Exercise26.4651,6001,365,50481,736Nov 26 05:06 PM
Contreras JaimeSenior Vice PresidentNov 25Sale44.0751,6002,274,08030,136Nov 26 05:06 PM
WHITE MILES DChairman and CEOOct 29Option Exercise22.2738,034846,9031,452,559Oct 30 06:04 PM
WHITE MILES DChairman and CEOOct 29Sale42.7038,0341,624,0521,414,525Oct 30 06:04 PM
WHITE MILES DChairman and CEOOct 28Option Exercise22.27402,7668,968,3911,817,291Oct 30 06:04 PM
WHITE MILES DChairman and CEOOct 28Sale42.50402,76617,117,6341,414,525Oct 30 06:04 PM
Fussell Stephen RExecutive Vice PresidentSep 18Option Exercise22.7931,900726,872141,664Sep 19 05:10 PM
FREYMAN THOMAS CExecutive Vice PresidentJul 21Option Exercise24.0779,0001,901,828390,326Jul 22 05:03 PM
Landgraf John CExecutive Vice PresidentJun 03Option Exercise31.9118,203580,771113,334Jun 05 05:09 PM
Blaser Brian JExecutive Vice PresidentMar 03Sale39.011,44156,219102,895Mar 04 05:07 PM
Mason Heather LSenior Vice PresidentMar 03Sale38.952,19685,540118,410Mar 04 05:07 PM
Funck Robert EVice President, ControllerMar 03Sale38.971,41355,06862,926Mar 04 05:05 PM
ALLEN HUBERT LExecutive Vice PresidentMar 03Sale39.031,54360,22952,525Mar 04 05:06 PM
Foltz Charles DSenior Vice PresidentMar 03Sale38.951,58861,85465,318Mar 04 05:06 PM
ASHLEY RICHARD WExecutive Vice PresidentMar 03Sale39.002,09881,829333,072Mar 04 05:06 PM
Warmuth Michael JExecutive Vice PresidentMar 03Sale39.0116,484642,96615,851Mar 04 05:04 PM
Contreras JaimeSenior Vice PresidentMar 03Sale39.378,081318,16030,136Mar 04 05:05 PM
FREYMAN THOMAS CExecutive Vice PresidentMar 03Sale39.102,984116,686311,326Mar 04 05:05 PM
Landgraf John CExecutive Vice PresidentMar 03Sale39.3817,293681,05795,131Mar 04 05:04 PM
Doyle Katherine C.Senior Vice PresidentMar 03Sale39.016,639258,96447,525Mar 04 05:04 PM